Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
Pluristem Therapeutics Collaborates with Pharmicell Europe GmbH to Distribute Pluristem's Cell Therapy Product for Clinical Trials in GermanyBusiness Wire(Tue 5:01am)